Related Experiment Video
Updated: Jul 28, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
A B-ALL Pediatric Patient with a Cryptic IGH Rearrangement Within the Context of a Complex Karyotype
Carlos A Tirado1,2,3, Sheila Dobin2,3, Krystal Eastwood2
1"The International Circle of Genetic Studies" Project, USA.
Insights
This case study details a 25-year-old male with B-cell acute lymphoblastic leukemia (B-ALL) and rare IGH gene rearrangements. Despite complex genetic abnormalities, the patient achieved a cytogenetic response to therapy with no residual disease.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- B-cell acute lymphoblastic leukemia (B-ALL) is a heterogeneous malignancy affecting both pediatric and adult populations.
- Characterized by the accumulation of immature B lymphoblasts, B-ALL necessitates precise diagnostic and prognostic evaluations.
- Immunophenotypic and cytogenetic analyses are crucial for understanding disease biology and guiding treatment strategies.
Purpose of the Study:
- To present a rare case of B-cell acute lymphoblastic leukemia (B-ALL) in a young adult male.
- To detail the complex genetic landscape, including immunoglobulin heavy chain (IGH) gene rearrangements, observed in this patient.
- To highlight the diagnostic and therapeutic implications of rare genetic abnormalities in B-ALL.
Main Methods:
- Bone marrow aspiration and analysis for B lymphoblasts and pancytopenia.
- Immunophenotyping using flow cytometry to identify cell surface markers (CD19, CD10, CD34, etc.).
- Cytogenetic analysis including complex karyotyping and fluorescence in situ hybridization (FISH) for IGH and MYC gene rearrangements.
Main Results:
- The patient presented with acute pre-B lymphoblastic leukemia, with 90% bone marrow infiltration by B lymphoblasts.
- Immunophenotyping revealed predominant immature precursor B lymphoid cells.
- Complex karyotype and significant IGH gene rearrangement (96.5%) were identified, with a gain of IGH signal also noted.
- FISH analysis refined the karyotype, identifying an add(8)(p11.2) with an IGH signal.
Conclusions:
- IGH gene abnormalities, though rare in B-ALL, can occur and are often linked to poorer prognoses.
- This case demonstrates a complex genetic profile in B-ALL with IGH rearrangement.
- Despite the rare genetic findings, the patient achieved a complete cytogenetic response to therapy, indicating potential for successful treatment even in complex cases.
Objectives:
B-cell acute lymphoblastic leukemia (B-ALL) can afflict both adult and pediatric patients and is characterized by a build-up of B lymphoblasts. Here we present a case of a 25-year-old male patient with a history of B-ALL. Ninety percent of the bone marrow revealed pancytopenia with sheets of B lymphoblasts consistent with the diagnosis of B-ALL for acute pre-B lymphoblastic leukemia. The immunophenotype also presented predominant immature precursor B lymphoid cells positive for CD19, CD10, CD34, CD58, CD38, CD9, and TdT. Chromosome analysis of the bone marrow showed a complex karyotype described as 45~47,XY,i(8)(q10),der(10)add(10)(p11.1)add(10)(q23),-20,+1~2mar[cp3]/46,XY[36]. While IGH rearrangements were cryptic cytogenetically, DNA FISH analysis showed evidence of the IGH (14q32.2) gene rearrangement in 96.5% of the nuclei examined. These results were described as nuc ish(IGHx2)(5'IGH sep 3'IGHx1)[187/200],(5'IGH,3'IGH)x1~4(5'IGH con 3'IGHx0~2) [6/200]. The remaining probes were normal. Further studies using the MYC/IGH DC, DF probe from Abbott showed a gain of IGH signal in 7.5% of the nuclei examined: nuc ish(MYCx2,IGHx3)[15/200]. Metaphase FISH also showed that what appeared to be an isochromosome 8q was a derivative chromosome 8 defined as add(8)(p11.2) that contained a green IGH signal. In light of these results the karyotype was characterized as 45~47,XY,add(8)(p11.2),der(10)add(10)(p11.1)add(10)(q23),-20,+1~2mar[cp3].ish add(8) (p11.2) IgH+. IgH abnormalities are rare in B-ALL and are usually associated with a poor prognosis. However, at the present time our patient presented no evidence of persistent or residual disease and a cytogenetic response to the present therapy.
Related Concept Videos
Karyotyping
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Pedigree Analysis
Crossing Over
Meiosis I

